World First For Advicenne’s Rare Kidney Disease Drug On The Cards
ADV7103 Could Become The First Approved Treatment For Distal Renal Tubular Acidosis
Advicenne should soon find out whether the European Medicines Agency will give its product, ADV7103, the thumbs up. Approval then wouldn’t be far off.
